Biotechnology AIM Immunotech FDA Lifts Hold, Stock Surges 25%By MohamedMis2July 29, 2023 In a significant development, the FDA has recently lifted its hold on AIM Immunotech. Resulting in a remarkable 25% surge…
Drug Manufacture InnoCare Revolutionizes Blood Cancer TreatmentBy MohamedMis2July 7, 2023 InnoCare, a leading biopharmaceutical company, has received approval in Hong Kong for the use of its tafasitamab combination therapy in…
